English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background   The correlation between platelet function and recurrent ischemic stroke or TIA remains uncertain.Objective   To investigate two inductive agents to detect platelet functions and assess associations with recurrent ischemic stroke/TIA.Method   The study included 738 ischemic stroke/TIA patients. On days 0, 3, and 9 after antiplatelet therapy, platelet function tests were determined by maximum aggregation rate (MAR) using a PL-11 platelet function analyzer and phase matching reagents. Two induction agents were used: arachidonic acid (AA) and adenosine diphosphate (ADP). At 3-month follow-up, recurrence of stroke/TIA was recorded.Result   Cut-off values of adequate platelet function inhibition were MAR ADP  < 35% and MAR AA  < 35%. Data showed that antiplatelet therapy could reduce the maximum aggregation rate. More importantly, adequate platelet function inhibition of either MAR ADP  or MAR AA  was not associated with the recurrence of stroke/TIA, but adequate platelet function inhibition of not only MAR ADP  but also MAR AA  predicts lower recurrence (0/121 (0.00%) versus 18/459 (3.92%),  P  = 0.0188).Conclusion   The platelet function tested by PL-11 demonstrated that adequate inhibition of both MAR ADP  and MAR AA  could predict lower risk of ischemic stroke/TIA recurrence.

Adequate Platelet Function Inhibition Confirmed by Two Inductive Agents Predicts Lower Recurrence of Ischemic Stroke/Transient Ischemic Attack